TYR

Overview

TYR encodes tyrosinase, the copper-dependent enzyme that performs the first and a subsequent rate-limiting step of melanin biosynthesis. Working inside the acidic lumen of melanosomes, tyrosinase hydroxylates the amino acid tyrosine to L-DOPA and then oxidizes L-DOPA to dopaquinone. Every other pigment produced by human melanocytes, whether the brown-black eumelanin that dominates dark skin and hair or the red-yellow pheomelanin that produces red hair, depends on this single enzymatic gateway. Because tyrosinase sits at the entry point of the pathway, its activity level effectively sets the ceiling on how much pigment a melanocyte can produce.

Tyrosinase is not a simple on-off switch. Its activity is tuned continuously by transcriptional control, largely through MITF, by cofactor availability in the form of copper, and by post-translational processing as the nascent protein folds and traffics from the endoplasmic reticulum through the Golgi to maturing melanosomes. This layered regulation explains why pigmentation can change so readily in response to UV exposure, hormonal shifts, and inflammation, without requiring any change in the underlying TYR gene sequence.

The gene also occupies an unusual dual role in human disease. On one hand, complete loss of tyrosinase activity causes oculocutaneous albinism type 1, a severe congenital condition affecting skin, hair, eyes, and vision. On the other hand, tyrosinase is one of the principal antigens recognized by the immune system in generalized vitiligo, so common regulatory variants in TYR shape susceptibility to an entirely different, autoimmune form of pigment loss. At the population level, more subtle common variants in TYR contribute to the ordinary range of skin, hair, and eye color seen across human groups, making this single gene relevant to albinism genetics, autoimmune dermatology, forensic pigmentation prediction, and cosmetic skin science all at once.

Deep Dive

Catalytic Mechanism and Copper Dependence

Tyrosinase belongs to the type-3 copper protein family, meaning its active site holds a pair of copper ions (denoted Cu-A and Cu-B) coordinated by conserved histidine residues. This binuclear copper center binds molecular oxygen and uses it to perform two chemically distinct reactions in sequence: a monophenolase reaction that hydroxylates tyrosine to L-DOPA, and a diphenolase reaction that oxidizes L-DOPA to dopaquinone. Because the monophenolase step is comparatively slow and requires a small amount of L-DOPA to prime the enzyme, tyrosinase activity is often described as rate-limiting for the entire melanogenic pathway, and this priming behavior is part of why melanocytes exposed to UV light show a lag before visible tanning becomes apparent.

Copper dependence also means tyrosinase activity is sensitive to cellular copper handling machinery, including copper chaperones that load the metal into the enzyme during its transit through the secretory pathway. A tyrosinase molecule that reaches the melanosome without properly loaded copper is catalytically inert even though its amino acid sequence is entirely normal, illustrating that pigment production depends on more than gene expression alone.

Melanosomal Trafficking and Enzyme Complex Assembly

Newly synthesized tyrosinase is a single-pass transmembrane glycoprotein. It must fold correctly in the endoplasmic reticulum, pass quality control checkpoints such as calnexin-mediated glycoprotein folding surveillance, and then traffic through the Golgi to maturing melanosomes. A substantial share of pathogenic TYR missense mutations act not by destroying the catalytic copper-binding residues directly but by destabilizing the folded protein enough that it is retained in the endoplasmic reticulum and degraded before ever reaching a melanosome. This distinction matters clinically, since some hypomorphic alleles retain partial folding efficiency and traffic just enough functional enzyme to allow residual pigment production, the molecular basis of the milder OCA1B phenotype.

Once inside the melanosome, tyrosinase does not act alone. It assembles into a multiprotein complex with TYRP1 and DCT, the two other members of the tyrosinase-related protein family. TYRP1 in particular appears to stabilize tyrosinase and help retain it within the melanosome, so that loss of TYRP1 function can secondarily reduce effective tyrosinase activity even when the TYR gene itself is intact.

Substrate Fate: DHI Versus DHICA Branches

After tyrosinase generates dopaquinone, the pathway branches. In the absence of further enzymatic processing, dopaquinone spontaneously cyclizes and rearranges into dopachrome, which then decarboxylates non-enzymatically to form 5,6-dihydroxyindole (DHI). DHI-derived melanin is chemically less stable and, in some experimental contexts, more prone to generating reactive byproducts. When DCT is present and active, it tautomerizes dopachrome into 5,6-dihydroxyindole-2-carboxylic acid (DHICA) instead, redirecting the pathway toward a route that, once oxidized by TYRP1, produces a more stable and orderly eumelanin polymer. Because TYR sets the total flux entering this branch point, its activity indirectly shapes not just how much melanin is made but, together with DCT and TYRP1, what kind of melanin polymer results.

Pathogenic Variants and Genotype-Phenotype Correlation in OCA1

Oculocutaneous albinism type 1 is caused by biallelic pathogenic TYR variants and is broadly divided into two clinical subtypes. OCA1A results from null alleles, typically frameshift, nonsense, or splice-site variants, or missense changes that eliminate catalytic copper coordination outright, producing complete, lifelong absence of melanin in skin, hair, and eyes. OCA1B results when at least one allele retains partial, often temperature-sensitive activity, as with the well-characterized R402Q variant, which folds and functions less efficiently at the higher temperatures found in central body regions than in cooler extremities. Individuals with OCA1B typically show minimal pigmentation at birth that gradually increases over childhood as residual enzyme activity accumulates melanin, a pattern that distinguishes it clinically from the unchanging depigmentation of OCA1A.

TYR as an Autoimmune Target in Vitiligo

Beyond congenital albinism, TYR is one of the best-characterized melanocyte autoantigens recognized by autoreactive T cells and antibodies in generalized vitiligo. Genetic studies using targeted resequencing have identified common regulatory TYR variants, distinct from the rare pathogenic OCA1 alleles, that alter how TYR-derived peptides are processed and presented to the immune system. These variants shift individual risk of developing generalized vitiligo, positioning TYR as a gene in which both loss-of-function coding mutations and subtler regulatory variation contribute to two mechanistically unrelated forms of pigment loss, one enzymatic and congenital, the other immune-mediated and acquired.

Biomarker and Testing Interpretation

Molecular sequencing of TYR, usually as part of a broader oculocutaneous albinism gene panel that also includes OCA2, TYRP1, and SLC45A2, has largely replaced older biochemical hair-bulb tyrosinase assays as the diagnostic standard, since it distinguishes OCA1 from other albinism subtypes with overlapping clinical presentations and predicts OCA1A versus OCA1B severity from genotype. Common pigmentation-associated TYR SNPs identified in genome-wide association studies are used mainly in forensic and ancestry-informative pigmentation prediction panels rather than in clinical diagnostics, and should not be interpreted as disease-causing in isolation.